Epigenetics in diagnosis, prognostic assessment and treatment of cancer: An update

Eleftheria Hatzimichael, Konstantinos Lagos, Van Ren Sim, Evangelos Briasoulis, Tim Crook (Lead / Corresponding author)

    Research output: Contribution to journalArticle

    5 Citations (Scopus)
    31 Downloads (Pure)

    Abstract

    Cancer cells contain multiple genetic and epigenetic changes. The relative specificity of many epigenetic changes for neoplastic cells has allowed the identification of diagnostic, prognostic and predictive biomarkers for a number of solid tumors and hematological malignancies. Moreover, epigenetically-acting drugs are already in routine use for cancer and numerous additional agents are in clinical trials. Here, we review recent progress in the development and application of epigenetic strategies for the diagnosis, risk stratification and treatment of cancer.
    Original languageEnglish
    Pages (from-to)954-976
    Number of pages23
    JournalEXCLI Journal
    Volume13
    Publication statusPublished - 26 Aug 2014

    Fingerprint Dive into the research topics of 'Epigenetics in diagnosis, prognostic assessment and treatment of cancer: An update'. Together they form a unique fingerprint.

  • Cite this

    Hatzimichael, E., Lagos, K., Sim, V. R., Briasoulis, E., & Crook, T. (2014). Epigenetics in diagnosis, prognostic assessment and treatment of cancer: An update. EXCLI Journal, 13, 954-976. http://www.excli.de/index.php